Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Find out Which Has Higher Fees Index Fund Or Target Date to prevent hidden costs. This overview covers expense drivers and decision tips.
28,473 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A major manager disclosed a sizable stake reduction in BXP, prompting questions about the outlook for Class A office ...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
The SEC approves WisdomTree's request for exemptive relief, unlocking 24/7 trading and near-instant settlement for to...
Long-term compound growth in tech requires durable moats and disciplined capital allocation. Here are two powerhouse ...
A solid move by a seasoned fund—Alpine Capital Research increases its Arrow Electronics position. Learn what this cou...
Investors weigh COPX, the copper miners ETF, against CPER, a copper futures fund, as EV and grid investments push cop...
Income investing isn't one-size-fits-all. This hands-on comparison weighs AGNC's high-yield potential against Realty ...
Social Security COLAs are meant to protect buying power, but there are three essential truths you need to know. This ...
A 2026 market backdrop prompts a fresh look at when to retire early. A saver chasing seven figures weighs the 4% rule...
Investors are watching for 2026 policy shifts as the Fed weighs inflation, growth, and job data. Learn what could mov...
A senior strategist has a bold projection for the S&P 500, arguing the index could reach 8,500 by end-2027 as a geopo...